AAM
Aureus Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,035
| Closed | -$408K | – | 186 |
|
|
2023
Q1 | $408K | Sell |
2,035
-528
| -21% | -$106K | 0.03% | 131 |
|
|
2022
Q4 | $609K | Hold |
2,563
| – | – | 0.05% | 114 |
|
|
2022
Q3 | $513K | Hold |
2,563
| – | – | 0.04% | 118 |
|
|
2022
Q2 | $374K | Hold |
2,563
| – | – | 0.03% | 141 |
|
|
2022
Q1 | $419K | Buy |
+2,563
| New | +$419K | 0.03% | 160 |
|
|
2016
Q4 | – | Sell |
-136,867
| Closed | -$9.28M | – | 163 |
|
|
2016
Q3 | $9.28M | Buy |
136,867
+3,016
| +2% | +$204K | 1.86% | 24 |
|
|
2016
Q2 | $7.43M | Buy |
133,851
+1,960
| +1% | +$109K | 1.6% | 28 |
|
|
2016
Q1 | $8.28M | Buy |
131,891
+65,256
| +98% | +$4.1M | 1.81% | 30 |
|
|
2015
Q4 | $6.27M | Buy |
+66,635
| New | +$6.27M | 1.41% | 29 |
|
|
2015
Q3 | – | Sell |
-34,808
| Closed | -$4.17M | – | 157 |
|
|
2015
Q2 | $4.17M | Sell |
34,808
-160
| -0.5% | -$19.2K | 0.88% | 41 |
|
|
2015
Q1 | $3.65M | Buy |
34,968
+170
| +0.5% | +$17.8K | 0.84% | 43 |
|
|
2014
Q4 | $3.38M | Hold |
34,798
| – | – | 0.82% | 44 |
|
|
2014
Q3 | $2.72M | Sell |
34,798
-49,983
| -59% | -$3.9M | 0.68% | 44 |
|
|
2014
Q2 | $5.36M | Buy |
+84,781
| New | +$5.36M | 1.34% | 39 |
|